© 2005 Oxford University Press
NEWS |
Awards, Appointments, Announcements
U.S. Food and Drug Administration Commissioner Lester Crawford, D.V.M., resigned on September 23, just 2 months after his Senate confirmation. National Cancer Institute Director Andrew von Eschenbach, M.D., has been named acting commissioner and will continue to head NCI. John Niederhuber, M.D., who recently joined NCI as deputy director for translational and clinical sciences, will serve as NCI's chief operating officer and handle the institute's day-to-day management while von Eschenbach heads the two organizations.
The H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., has announced two new appointments.
Christine Laronga, M.D., has been named associate professor of surgery in the Don and Erika Wallace Comprehensive Breast Program.
Mohamed Kharfan-Dabaja, M.D., has been appointed assistant professor in the Blood and Marrow Transplantation Program.
Scott Leischow, Ph.D., has been appointed as a deputy director of the Arizona Cancer Center in Tucson. Leischow had been on detail from the National Cancer Institute to the Office of the Secretary in the Department of Health and Human Services, where he served as senior advisor for tobacco policy.
Jeffrey Strathern, Ph.D., has been appointed deputy director of CCR-Frederick, the National Cancer Institute's Center for Cancer Research facility in Frederick, Md.
Thomas Lönngren has been reappointed as executive director of the European Medicines Agency. His new appointment runs until December 2010.
Douglas Throckmorton, M.D., has been named deputy director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. Throckmorton has been acting deputy director since May 2004.
Two cancer researchers have been named 2005 MacArthur Fellows and will receive a stipend of $500,000 over 5 years.
Sue Goldie, M.D., associate professor of health decision science at the Harvard University School of Public Health in Boston, studies the human papillomavirus (HPV) and its link to cervical cancer.
Olufunmilayo Olopade, M.D., director of the cancer risk clinic and professor of medicine and human genetics at the University of Chicago, was selected for her work translating findings on the molecular genetics of breast cancer in African and African American women into clinical practices in the United States and abroad.
Stephen M. Hahn, M.D., has been named the new Chair and Henry K. Pancoast Professor of Radiation Oncology at the University of Pennsylvania School of Medicine in Philadelphia. Hahn joined Penn in 1996 and is also the program leader of the Radiation Biology Research Program in the Abramson Cancer Center.
Richard I. Fisher, M.D., has been named deputy chair of the Southwest Oncology Group. Fisher is director of the University of Rochester Medical Center's James P. Wilmot Cancer Center and Director of Cancer Services for Strong Health.
Roswell Park Cancer Institute in Buffalo, N.Y., has made two new appointments.
Juan-Diego Harris, M.D., has joined the Department of Pain Medicine.
Naoyuki G. Saito, M.D., Ph.D., has joined the Departments of Radiation Medicine and Pharmacology and Therapeutics.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||